genedit.com

Genedit

Genedit's email is park@genedit.com .

GenEdit was founded to transform the delivery of gene therapies and enable the next generation of non-viral, gene editing-based therapeutics. GenEdit’s proprietary technology, NanoGalaxy™ platform solves current delivery challenges by systematically screening its nanoparticle library and providing safer and efficient delivery to target tissues. The company's tool makes therapeutic gene editing possible and is easier to use, faster and more accurate than previous gene-editing techniques and thus has the potential for a wide range of therapeutic applications, enabling phys...

read more

GenEdit was founded to transform the delivery of gene therapies and enable the next generation of non-viral, gene editing-based therapeutics. GenEdit’s proprietary technology, NanoGalaxy™ platform solves current delivery challenges by systematically screening its nanoparticle library and providing safer and efficient delivery to target tissues. The company's tool makes therapeutic gene editing possible and is easier to use, faster and more accurate than previous gene-editing techniques and thus has the potential for a wide range of therapeutic applications, enabling physicians to cure incurable genetic diseases.

show less

View Top Employees for Genedit
img Website genedit.com
img Industry Biotechnology
img Location South San Francisco, California, United States
img Employees 17
img Founded 2016
img Email park@genedit.com
img Funding 43,725,000 USD
img Competitors Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences,
img Website genedit.com
img Industry Biotechnology
img Location South San Francisco, California, United States
img Employees 17
img Founded 2016
img LinkedIn linkedin.com/company/genedit
img Email park@genedit.com
img Funding 43,725,000 USD

Top Genedit Employees